Levobupivacaine During Cholecystectomy

This study has been completed.
Sponsor:
Information provided by:
Ege University
ClinicalTrials.gov Identifier:
NCT00836316
First received: February 3, 2009
Last updated: NA
Last verified: February 2009
History: No changes posted

February 3, 2009
February 3, 2009
Not Provided
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Levobupivacaine During Cholecystectomy
Effects of Intraperitoneal Levobupivacaine on Pain After Laparoscopic Cholecystectomy: A Prospective, Randomized, Double-Blinded Study

The purpose of this study is to determine the effects of intraperitoneal administration of levobupivacaine on pain after laparoscopic cholecystectomy.

Not Provided
Interventional
Phase 4
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment
  • Cholelithiasis
  • Pain
Drug: levobupivacaine
intraperitoneal administration of levobupivacaine on pain after laparoscopic cholecystectomy
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
40
Not Provided
Not Provided

Inclusion Criteria:

  • cholelithiasis
  • chronic cholecystitis

Exclusion Criteria:

  • hypersensitivity to local anesthetics
  • acute cholecystitis
  • morbid obesity
Both
18 Years to 50 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Turkey
 
NCT00836316
LDC-2008
Not Provided
Not Provided
Ege University
Not Provided
Not Provided
Ege University
February 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP